“Real-world” evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy

Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries

Martin C. S. Wong, William B. Goggins, Haoxiang Wang et al. · European Urology · 2016 · 533 citations · Full text

Medicine, Oncology, Urology +16

The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Bernd J. Krause, Michael Souvatzoglou, Murat Tuncel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 367 citations

Medicine, Nuclear Medicine, Oncology +17

Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience

Ali Afshar‐Oromieh, Uwe Haberkorn, HP Schlemmer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 326 citations

Medicine, Nuclear Medicine, Oncology +16

Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer

Daniela B. Husarik, Raymond Miralbell, Markus Dubs et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 296 citations

Medicine, Nuclear Medicine, Radiology +12

¹⁸F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients

Mohsen Beheshti, Larisa Imamovic, Gabriele Broinger et al. · Radiology · 2010 · 271 citations

Medicine, Nuclear Medicine, Oncology +17